BioSpace News Archive

Biotech Bay

Verseon Showcases Candidates for Next-Generation Diabetic Eye Disease Drugs

- Verseon presented their oral drug candidates for diabetic macular edema (DME) at this week’s 2019 BIO International Convention in Philadelphia.

June 4, 2019
·
3 min read
Drug Development

Beactica Secures Another Round of Financing as Novel Glioblastoma Treatment Advances Towards Pre-clinical Development

Beactica AB, the Swedish drug discovery company, announced the completion of a new financing round that will enable the company to take its leading pipeline programme in oncology to the next stage.

June 4, 2019
·
2 min read
Medivir to Present at the 2019 BIO International Convention

Medivir AB announces that the company will participate at the 2019 BIO International Convention in Philadelphia, US.

June 4, 2019
·
1 min read
Drug Development

Camurus Announces Publication of Phase 3 Study Results Showing Long-term Safety, Efficacy and High Rates of Patient Satisfaction With Buvidal®

Camurus announces that the leading drug dependence journal Addiction has published full results from a 48-week, open-label, global Phase 3 study of weekly and monthly Buvidal®, the first and only long-acting injection medicine to be approved for the treatment of opioid dependence in the EU and Australia.

June 4, 2019
·
6 min read
Juniper Research: Future Digital Awards for Technology & Innovation 2019: Nominations Open!

Nominations for the Future Digital Awards for Technology & Innovation 2019 are now open.

June 4, 2019
·
2 min read
Biotech Beach

First Criminal Conviction Secured with Next-Gen Forensic DNA Technology

DNA profiles generated on a MiSeq® system were critical evidence in landmark Dutch case.

June 4, 2019
·
3 min read
Drug Development

CEPI Awards up to US$21 Million to Themis Bioscience for Phase 3 Chikungunya Vaccine Development

Funding will support this registration study and rapid global availability of the vaccine against Chikungunya

June 4, 2019
·
7 min read
Deals

A Step Forward For Digital Identity: CertiPath And ZEVA Acquire SAFE-BioPharma

CertiPath and ZEVA have jointly acquired SAFE-BioPharma.

June 4, 2019
·
2 min read
Biotech Beach

Innovus Pharma Expands its OTC Drug Pipeline with the Addition of OmepraCare™ (a Competitor of Prilosec® OTC)

This New Drug OmepraCare™ is Indicated for the Treatment of Frequent Heartburn and is Expected to add Significant Revenue to the Company

June 4, 2019
·
4 min read
Job Trends

Caris Life Sciences to Present at Jefferies 2019 Healthcare Conference

Caris Life Sciences® announced that Brian J. Brille, Vice Chairman of the Company, will present at the Jefferies 2019 Healthcare Conference on Friday, June 7, 2019, at 8:30 a.m. Eastern time.

June 4, 2019
·
1 min read